The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Shares of Eli Lilly & Co. LLY inched 0.91% higher to $795.35 Friday, on what proved to be an all-around favorable trading ...

Eli Lilly’s strong position in GLP-1 drugs is overlooked by the market. Find out why LLY stock is a buy even as others pull ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion ...

The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' ...

The stock has also performed well this year, rising roughly 36% (as of Nov. 14), ahead of the broader market. Given that Eli ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

As far as competition goes, Eli Lilly is one of the two current leaders in the weight loss space, along with Novo Nordisk.

Gov. Eric Holcomb said Clay Robbins' "humble service to our great state truly represents the very best of what it means to be ...

LLY stock struggles, falling 16.85% over the last month due to bearish technicals and political uncertainty. But with ...